首页> 外文期刊>Parassitologia >Advances in the development of molecular tools for the control of bovine babesiosis in Mexicoz
【24h】

Advances in the development of molecular tools for the control of bovine babesiosis in Mexicoz

机译:墨西哥控制牛杆状杆菌病的分子工具开发进展

获取原文
获取原文并翻译 | 示例
       

摘要

The severe negative impact that bovine babesiosis has in the Mexican cattle industry has not been ameliorated basically due to the lack of safe and effective commercially available vaccines and sensitive and reliable diagnostic tests. In recent years,the Bovine Babesiosis Laboratory at the National Center for Disciplinary Research in Veterinary Parasitology-INIFAP in Morelos State, Mexico has been directing efforts towards three main research areas: (1) The development of in vitro culture-derived, improved and safer live vaccines. This has been done in two ways: using gamma-irradiated bovine serum and ery-throcytes for the in vitro culture of vaccine strains, which reduces the risk of contaminating pathogens, and improving the immune response, by the addition of L. case/, a strong stimulant of the innate immune system. (2) The study of antigens considered as vaccine candidates with the goal of developing a recom-binant vaccine that suits the country's needs. Knowing their degree of conservation orvariation in Mexican isolates, their phylogenetic relationship and their protective, immuno-stimulatory properties, are first steps towards that goal. (3) The development of new tools for diagnosis, detection and discrimination of bovine babesiosis is the third area. Developing variants of ELISA, which are more reliable than the currently used FAT, are a priority, and finally, taking advantage of the genomes of Babesia bigemina, and B. bow's, we are identifying genes than allow us to discriminate isolates using molecular tools.
机译:基本上由于缺乏安全有效的市售疫苗以及灵敏可靠的诊断测试,牛杆状杆菌病对墨西哥牛业的严重负面影响尚未得到缓解。近年来,位于墨西哥莫雷洛斯州国家兽医寄生虫学学科研究中心(INIFAP)的牛杆状病毒实验室一直致力于以下三个主要研究领域:(1)体外培养衍生,改良和更安全的发展活疫苗。这通过两种方式完成:使用伽玛射线照射的牛血清和红细胞进行疫苗株的体外培养,从而降低了污染病原体的风险,并通过添加L. case /来改善免疫反应。对先天免疫系统的强烈刺激。 (2)研究被认为是候选疫苗的抗原,目的是开发适合该国需求的重组疫苗。知道它们在墨西哥分离物中的保守或变异程度,它们的系统发生关系以及它们的保护性,免疫刺激性,是迈向该目标的第一步。 (3)第三部分是开发用于诊断,检测和鉴别牛杆状杆菌病的新工具。优先开发比目前使用的FAT更为可靠的ELISA变体,最后,利用巴贝斯虫(Babesia bigemina)和B. bow's的基因组,我们正在鉴定基因,而不是允许我们使用分子工具区分菌株。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号